MedPath

1,2-Distearoyllecithin

Generic Name
1,2-Distearoyllecithin
Brand Names
Lumason
Drug Type
Small Molecule
Chemical Formula
C44H88NO8P
CAS Number
4539-70-2
Unique Ingredient Identifier
EAG959U971

Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke

Early Phase 1
Completed
Conditions
Stroke, Acute
Interventions
Diagnostic Test: SONAS Ultrasound Device
First Posted Date
2017-09-28
Last Posted Date
2019-03-26
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
12
Registration Number
NCT03296852
Locations
🇺🇸

UCLA Medical Center, Los Angeles, California, United States

Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children

Phase 1
Terminated
Conditions
Abdominal Injury
Interventions
First Posted Date
2017-05-10
Last Posted Date
2021-06-11
Lead Sponsor
David Mooney
Target Recruit Count
74
Registration Number
NCT03147690
Locations
🇺🇸

Riley Children's Health, Indianapolis, Indiana, United States

🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

🇺🇸

Nationwide Children's, Columbus, Ohio, United States

and more 5 locations

Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH

Early Phase 1
Recruiting
Conditions
Developmental Dysplasia of the Hip
Interventions
Diagnostic Test: Intraoperative contrast-enhanced ultrasound (CEUS)
First Posted Date
2017-04-11
Last Posted Date
2025-04-17
Lead Sponsor
Children's Hospital of Philadelphia
Target Recruit Count
125
Registration Number
NCT03107520
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses

Phase 4
Terminated
Conditions
Liver Biopsy
Interventions
First Posted Date
2017-02-02
Last Posted Date
2019-08-08
Lead Sponsor
Indiana University
Target Recruit Count
83
Registration Number
NCT03040323
Locations
🇺🇸

Indiana University Health, Indianapolis, Indiana, United States

Contrast-Enhanced Ultrasound for Kidney Transplant

Phase 1
Terminated
Conditions
Kidney Transplantation
Interventions
First Posted Date
2016-09-22
Last Posted Date
2024-06-21
Lead Sponsor
Isaac E. Hall
Target Recruit Count
20
Registration Number
NCT02911714
Locations
🇺🇸

University of Utah Hospital, Salt Lake City, Utah, United States

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

Phase 3
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2015-09-17
Last Posted Date
2021-07-07
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
174
Registration Number
NCT02552238
Locations
🇧🇪

Cliniques Universitaires Saint-Luc Unité de Pathologie Cardio-Vasculaire / Cardiologie, Bruxelles, Belgium

🇧🇪

Antwerp University Hospital, Edegem, Belgium

🇺🇸

Ochsner Clinic Foundation, New Orleans, Louisiana, United States

and more 10 locations

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141

Phase 3
Completed
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2015-08-13
Last Posted Date
2021-06-11
Lead Sponsor
Bracco Diagnostics, Inc
Target Recruit Count
175
Registration Number
NCT02522481
Locations
🇺🇸

University of California San Diego, La Jolla, California, United States

🇺🇸

Community Heart and Vascular Community Hospital East, Indianapolis, Indiana, United States

🇺🇸

North Kansas City Hospital, North Kansas City, Missouri, United States

and more 14 locations
© Copyright 2025. All Rights Reserved by MedPath